Digoxin use in congestive heart failure

Drugs

Volumn 55, Issue 6, 1998, Pages 747-758

  Riaz, Kamran ^a   Forker, Alan D ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b TRUMAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IBOPAMINE; MILRINONE;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG WITHDRAWAL; EXERCISE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; META ANALYSIS; REVIEW; SAMPLE; SINUS RHYTHM; SURVIVAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; CARDIOTONIC AGENTS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MULTICENTER STUDIES; MYOCARDIAL CONTRACTION; RANDOMIZED CONTROLLED TRIALS;

DIGITALIS;

EID: 0031860018     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199855060-00002     Document Type: Review

References (62)

1. Withering, W. An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. In: Woolliest FA, Keys TE, editors. Classics of cardiology. New York: Henry Schuman, Dover Publications, 1941: Vol. 1: 231-52
2. Christian HA. Digitalis effects in chronic cardiac cases with regular rhythm in contrast to auricular fibrillation. Med Clin North Am 1922; 5: 117-9
3. Hollman A. American College of Cardiology ACCEL tape, 1997 Jun
4. Poole-Wilson P, Robinson K. Digoxin a redundant drug in congestive cardiac failure. Cardiovasc Drugs Ther 1989; 2: 733-41
5. Weber KT. Heart failure: lessons learned over the past 25 years. Clin Cardiol 1995; 18: 123-30
6. Gheorghiade M, Zarowitz BJ. Review of randomized trials of digoxin therapy in patients with chronic heart failure. Am J Cardiol 1992: 48G-62G
7. Tauke J, Goldstein S, Gheorghiade M. Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED and RADIANCE Trials. Prog Cardiovasc Dis 1994; 37: 49-58
8. Gheorghiade M, Digoxin. In: Crawford MH, editor. Cardiology Clinics: annual drug therapy. Philadelphia (PA): WB Saunders, 1997: volume 1: 81-103
9. Starr I, Luchi RJ. Blind study of the action of digitoxin on elderly women. Am Heart J 1969; 78: 740-51
10. Dall JLC. Maintenance digoxin in elderly patients. BMJ 1970; 2: 705-6
11. Kirsten E, Rodstein M, Iuster Z. Digoxin in the aged. Geriatrics 1973; 1: 95-101
12. Fonrose HA, Ahlbaum N, Bugatch E, et al. The efficacy of digitalis withdrawal in an instructional aged population. J Am Geriatr Soc 1974; 22: 208-11
13. Hull SM, MacKintosh A. Discontinuation of maintenance digoxin therapy in general practice. Lancet 1977; 2: 1054-5
14. Johnston GD, McDevitt DG. Is maintenance digoxin necessary in patients with sinus rhythm? Lancet 1979; 1: 567-70
15. McHaffie D, Purcell H, Mitchell-Heggs P, et al. The clinical value of digoxin in patients with heart failure and sinus rhythm. Q J Med 1978; 47: 401-19
16. Krakauer R, Petersen B. The effects of discontinuing maintenance digoxin therapy. Dan Med Bull 1979; 26: 10-3
17. Hutcheon D, Memeth E, Quinlan D. The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure. J Clin Pharmacol 1980; 20: 54-68
18. Arnold SB, Bird RC, Meister W, et al. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 1980; 303: 1443-8
19. Sommers DeK, Reitz CJ, Koch Z, et al. Digoxin withdrawal with patients in sinus rhythm. S Afr Med J 1981; 60: 239-40
20. Murray RG, Tweddel AC, Martin W, et al. Evaluation of digitalis in cardiac failure. BMJ 1982; 284: 1526-8
21. Griffiths BE, Penny WJ, Lewis MJ, et al. Maintenance of the inotropic effects of digoxin on long-term treatment. BMJ 1982; 284: 1819-22
22. Gheorghiade M, Beller GA. Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol 1983; 51: 1243-50
23. Yusuf S, Garg R, Held P, et al. Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure. Am J Cardiol 1992; 69: 64G-70G
24. Dobbs SM, Kenyon WI, Dobbs RJ. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. BMJ 1977; 1: 749-52
25. Fleg JL, Gottlieb SH, Lakatta EG. Is digoxin really important in treatment of compensated heart failure? Am J Med 1982; 73: 244-50
26. Lee C, Johnson RA, Bingham GB, et al. Heart failure in outpatients. N Engl J Med 1982; 306: 699-705
27. Taggart AJ, Johnston GD, McDevitt DG. Digoxin withdrawal after cardiac failure in patients with sinus rhythm. J Cardiovasc Pharmacol 1983; 5: 229-34
28. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial digoxin in congestive heart failure. Am J Cardiol 1988; 61: 371-5
29. Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539-44
30. German and Austrian Xamoterol Study Group. Double blind placebo-controlled comparison of digoxin and xamoterol in congestive heart failure. Lancet 1988; 1: 489-93
31. Dibianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in treatment of patients with chronic heart failure. N Engl J Med 1989; 320: 677-83
32. Pugh SE, White NJ, Arnson JK, et al. Clinical, hemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment. Br Heart J 1989; 61: 529-39
33. Fleg JL, Rothfeld B, Gottlieb SH, et al. Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled crossover trial. J Am Coll Cardiol 1991; 17: 743-51
34. Jaeschke R, Oxman AD, Guatt GH. To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin? A systematic review and meta-analysis. Am J Med 1990; 88: 279-86
35. Alicandri C, Fariello R, Boni E, et al. Captopril versus digoxin in mild-moderate chronic heart failure: a crossover study. J Cardiovasc Pharmacol 1987; 9: S61-7
36. Beaune J. Comparison of enalapril versus digoxin for congestive heart failure. Am J Cardiol 1989; 63: 22D-5D
37. Kromer EP, Elsner D, Riegger GAJ. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm. J Cardiovasc Pharmacol 1990; 16: 9-14
38. Davies RF, Beanlands DS, Nadeau C, et al. Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. J Am Coll Cardiol 1991; 18: 1602-9
39. Drexler H, Schumacher M, Siegrist J, et al. Effect of captopril and digoxin on quality of life and clinical symptoms in patients with coronary artery disease and mild heart failure [abstract]. J Am Coll Cardiol 1992; 19: 260A
40. Uretsky BF, Young JB, Shahidi FE, et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure. J Am Coll Cardiol 1993; 22: 955-62
41. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993; 329: 1-7
42. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33
43. Sonnenblick EH, Williams JF, Glick G, et al. Studies on digitalis: XV. Effects of cardiac glycosides on myocardial force-velocity relations in the nonfailing human heart. Circulation 1966; 34: 532-9
44. Braunwald E. In: Isselbacher KJ, Wilson JD, Martin JB, et al. Harrison's Principles of internal medicine, 14th ed. New York: McGraw-Hill, 1998: 1294-5
45. Van Veldhuisen DJ, DeGraeff PA, Remme WJ, et al. Value of digoxin in heart failure and sinus rhythm: new features of an old drug? J Am Coll Cardiol 1996; 28: 813-9
46. Rabimtoola SH, Tak T. The use of digitalis in heart failure. Curr Prob Cardiol 1996; 32: 826-7
47. Gheorghiade M, St Clair J, St Clair C, et al. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1987; 9: 849-57
48. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-54
49. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55
50. Ferguson D, Berg WJ, Sanders JS, et al. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation 1989; 80: 65-77
51. Ferguson DW. Digitalis and neurohormonal abnormalities in heart failure and implications for therapy. Am J Cardiol 1992; 69: 24G-32G
52. Krum H, Bigger JT, Goldsmith RL, et al. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995; 25: 289-94
53. Brouwer J, Van Veldhuisen DJ, Veld AJM, et al. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulalion by digoxin and ibopamine. J Am Coll Cardiol 1995; 26: 983-90
54. Van Veldhuisen DJ, Veld AJM, Dunselman PHJM, et al. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch lbopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993; 22: 1564-73
55. Marcus F, Digitalis. In: Singh BN, Dzau VJ, Van Houtte PM, et al., editors. Cardiovascular pharmacology and therapeutics. New York: Churchill Livingston, 1994: 345
56. Gheorghiade M, Hall VV, Jacobsen G, et al. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation 1995; 92: 1801-7
57. Slatton ML, Irani WN, Hall SA, et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure in normal sinus rhythm? J Am Coll Cardiol 1997; 29: 1206-13
58. Gheorghiade M. Serum digoxin doses below 1ng/mL held safer [interview]. Intern Med News, 1997 Aug 15
59. Mancini DM, Benotti JR, Elkayam U, et al. Antiarrhythmic drug use and high serum levels of digoxin are independent adverse prognostic factors in patients with chronic heart failure [abstract]. Circulation 1991; 84 Suppl. II: 243
60. Agency for Health Care Policy and Research. Clinical Practice Guideline No. 11. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Rockville (MD): US Department of Health and Human Services, 1994: publication no. 94-0612
61. Van Veldhuisen DJ, Brouwer J, Veld AJM, et al. Progression of mild untreated congestive heart failure during 6 months followup and clinical and neurohormonal effects of ibopamine and digoxin as monotherapy. Am J Cardiol 1995; 75: 796-800
62. ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995; 26: 1376-98